ALCOX
NicOx
Stock Euronext / Paris – Stock Market Prices, News & Analysis
NicOx S.A. is a biopharmaceutical company focused on the research and development of innovative therapeutic solutions primarily in the field of ophthalmology.
NicOx
ALCOX
NicOx S.A. is a biopharmaceutical company focused on the research and development of innovative therapeutic solutions primarily in the field of ophthalmology.
Price history of NicOx
Price history of NicOx
Performance & Momentum
NicOx boosts cash and plans NCX 470 filing in 2026
NicOx S.A. has fully repaid its Kreos Capital debt, extending its cash runway beyond 2027 following a new €4 million unsecured bond issuance with Vester Finance. The company has also finalized key data for the NCX 470 new drug application, planned for H1 2026 in the U.S. and China, following positive preliminary FDA feedback. Clinical results demonstrate sustained 12-month efficacy with no new safety concerns, strengthening the drug candidate's outlook. These developments solidify NicOx's financial position and pave the way for medium-term growth potential, potentially supporting its stock valuation.
Similar stocks to NicOx
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
